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Introduction 
The human skeleton is structurally unyielding due to its high mineral content, yet 
highly adaptive as it is dynamically remodeled throughout life to meet our daily needs. 
The process of bone remodeling is primarily carried out by two types of cells, osteoblasts 
and osteoclasts. Osteoblasts synthesize the protein matrix that mineralizes to become 
bone; whereas osteoclasts demineralize and resorb bone. The intricate balance between 
their activities is critical for bone homeostasis, and any disruption of this harmonious 
relationship can lead to both systemic and localized diseases, such as osteoporosis, 
osteolytic malignancies, and periodontitis (Zaidi, 2007). Osteoblasts and osteoclasts are 
tightly regulated by systemic hormones and locally produced cytokines, such as bone 
morphogenetic proteins (BMPs) (Biver, Hardouin, & Caverzasio, 2013; Giannoudis, 
Kanakaris, & Einhorn, 2007). BMPs have long established themselves as direct positive 
regulators of osteoblastic activity; however, their influences on osteoclasts have been 
controversial. Recent work from the Gopalakrishnan/Mansky lab has provided 
convincing evidence that BMP signaling directly upregulates osteoclastogenesis induced 
by RANKL and M-CSF (Broege et al., 2013; Jensen et al., 2010; Sotillo Rodriguez et al., 
2009). Upon binding of the cell surface BMP receptors, BMPs exert their regulatory 
effects through the activation of two distinct intracellular pathways: the canonical 
pathway involving Smad proteins and the non-canonical pathway involving the MAP 
kinases (Biver et al., 2013). The goal of this project is to further investigate the specific 
role of the canonical Smad pathway of BMP signaling in osteoclastogenesis. 
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Review of the Literature 
The skeleton provides protection for our key organs, at the same time; it serves as 
a rigid framework to which muscles attach in order to perform our motor activities. While 
its inner cavity holds a reservoir of bone marrow/stem cells that constantly replenish new 
blood cells, the mineralized bone itself is the body’s major storage of calcium and 
phosphate for the maintenance of mineral homeostasis in the body (Henriksen, Neutzsky-
Wulff, Bonewald, & Karsdal, 2009; Zaidi, 2007). All in all, it is a highly versatile and 
indispensable organ of our bodies.  
 
Bone Cells 
As the weight bearer of the body, the bone is constantly challenged by high load, 
which inevitably leads to structural damage.  Yet, we do not crumble to pieces because of 
continuous bone remodeling mediated by two key bone cells: osteoblasts and osteoclasts. 
Bone remodeling describes the process by which old damaged bone is resorbed away by 
osteoclasts and subsequently replaced with new bone by osteoblasts (Henriksen et al., 
2009; Zaidi, 2007). Osteoblasts are of mesenchymal origin and their main function is to 
produce bone by secreting osteoid (unmineralized protein matrix). As they become 
embedded in bone, they differentiate into osteocytes.  In addition, osteoblasts regulate the 
bone resorbing cell, osteoclasts, via releasing extracellular mediators, such as RANKL 
and OPG (Mellis, Itzstein, Helfrich, & Crockett, 2011). Osteoclasts belong to the 
monocyte/macrophage lineage of hematopoietic origin (Väänänen & Laitala-Leinonen, 
2008). Their differentiation begins as mononuclear precursor cells and, through cell-cell 
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fusion, they become multi-nucleated cells able to resorb bone (Mellis et al., 2011).  The 
balance of osteoblastic and osteoclastic function has a direct effect on the integrity of 
bone. When osteoclastic activity is too exaggerated, bone pathologies such as 
osteoporosis, rheumatoid arthritis, periodontitis, and osteolytic malignancies can occur 
(Yavropoulou & Yovos, 2008). 
 
Osteoclastogenesis 
Due to the aforementioned morbidity and mortality associated with over-
abundance of osteoclastic activity, the process of osteoclast differentiation 
(osteoclastogenesis) is heavily researched; however, the regulatory mechanisms 
controlling osteoclastogenesis are still not fully understood at the present time. Starting 
from the pluripotent hematopoietic stem cells, granulocyte-macrophage colony forming 
unit (GM-CFU) is the earliest identifiable precursor to osteoclasts (Menaa, Kurihara, & 
Roodman, 2000). To commit to the osteoclast cell fate, osteoclast progenitor cells depend 
on the activation of surface receptors, c-FMS and RANK, by M-CSF (macrophage 
colony stimulating factor) and RANKL (Receptor Activator of Nuclear Factor-κB 
ligand), respectively, to promote proliferation and prevent apoptosis. The co-stimulation 
from M-CSF and RANKL continues to be critical in the differentiation of immature 
precursor cells to mononuclear TRAP+ preosteoclasts as they induce the expression of 
key transcription factors, such as PU.1, MIFT, c-FOS, and NFATc1. Finally, under the 
expression of master fusion regulator, DC-STAMP, fusion of mononuclear precursors 
takes place to form mature multinuclear osteoclasts (reviewed in (Mellis et al., 2011 ). 
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The RANK/RANKL/OPG regulatory axis 
Although osteoblasts and osteoclasts have antagonistic effects on bone volume, 
the traditional model describes osteoblasts as the major cell type to regulate the 
recruitment and differentiation of osteoclasts through the release of RANKL and OPG. 
RANKL belongs to the tumor necrosis factor (TNF) superfamily and is normally 
expressed on the surface of osteoblasts and bone marrow stromal cells to promote 
osteoclast differentiation upon binding to its receptor RANK on osteoclast precursor 
cells. However, emerging data recently have supported the idea that the osteocytes, 
typically described as quiescent cells embedded in bone, actually may be the major 
source of RANKL to support osteoclastogenesis. Nakashima et al. demonstrated that 
isolated osteocytes expressed larger quantities of RANKL and supported osteoclast 
differentiation better than osteoblasts did. They also showed that a lack of RANKL 
expression specifically from osteocytes led to a severe osteopetrotic phenotype 
(Nakashima et al., 2011). The loss of RANKL leads to defect in osteoclastogenesis and 
an osteopetrotic phenotype in vivo and in vitro (Kong et al., 1999; J. Li et al., 2000). 
Osteoprotegrin (OPG) act as a decoy receptor that sequestrates RANKL from binding 
RANK when its activation is undesired (Udagawa et al., 2000). Figure 1 shows the model 
of RANKL/RANK/OPG interaction. As expected, over-expression of OPG leads to a 
similar phenotype as RANKL deficiency (J. Li et al., 2000). Through modulating the 
ratio of RANKL and OPG secreted from osteoblasts, systemic hormones, such as 
parathyroid hormone (PTH), 1,25 (OH)2 vitamin D3, calcitonin, and local paracrine and 
autocrine factors can influence osteoclastogenesis (Boyle, Simonet, & Lacey, 2003). 
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Figure 1. Osteoblast and stromal cells expression RANKL on their cell surface and 
release OPG into extracellular space. Upon cell-cell contact, RANKL binds RANK on 
the surface of osteoclast precursors and stimulates osteoclast differentiation and 
activation. OPG acts as a decoy receptor to prevent binding of RANKL to RANK. 
 
Genes Involved in the Differentiation and Fusion of osteoclast 
NFAT (Nuclear Factor of Activated T-cells) 
Nuclear Factor of Activated T cells (NFAT) is a family of transcription factors 
that is determined to be necessary and sufficient for osteoclastogenesis. In vitro studies 
demonstrated that homozygous knockout of NFATc1 completely disrupts the formation 
of osteoclast from embryonic stem cells, and ectopic-expression of constitutively active 
NFATc1 can induce osteoclast differentiation in the absence of normally required 
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RANKL stimulation (Takayanagi et al., 2002). Upon stimulation by RANKL, increased 
intracellular Ca2+ level activates the Ca2+/calmodulin-dependent calcineurin, which leads 
to the nuclear translocation of NFATc1 (Takayanagi, 2007). Subsequently, NFATc1 up-
regulates the expression of several osteoclast-specific genes, including cathepsin K 
(Ctsk), acid phosphatase 5 (Acp5), osteoclast-associated receptor (OSCAR), and 
calcitonin receptor (CTR) to promote differentiation. 
 
Dendritic Cell-Specific Transmembrane Protein (DCSTAMP) and the d2 isoform of 
vacuolar ATPase Vo Domain (Atp6v0d2) 
The cardinal feature of osteoclasts is the multinucleation by cell-cell fusion of 
mononuclear osteoclasts into a multinuclear osteoclast, which is essential for efficient 
bone resorption. Dendritic cell-specific transmembrane protein (DCSTAMP) is a seven-
transmembrane surface protein whereas Atp6v0d2 is a component of the vacuolar 
ATPase proton pump involved in extracellular acidification (Lee et al., 2006; Miyamoto, 
2011). When RANK is activated, NFATc1 positively regulates the expression of fusion 
genes, DC-STAMP and Atp6v0d2 to promote multinucleation (Kim, Lee, Ha Kim, Choi, 
& Kim, 2008). DC-STAMP deficient mice, both in vivo and in vitro, have abundant 
mononuclear osteoclasts with normal expression of osteoclast differentiation markers but 
are completely void of any multinuclear osteoclasts, indicating that DC-STAMP is 
specifically required for cell-cell fusion but is not involved in osteoclast differentiation 
(Yagi et al., 2005). Similarly, v-ATPase Vo subunit d2-deficient mice demonstrated an 
osteopetrotic phenotype due a decreased bone resorptive activity from the lack of 
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multinuclear osteoclasts (Lee et al., 2006). The fact that bone resorption is not completely 
lost in DC-STAMP/v-ATPase deficient mice suggests that mononuclear osteoclasts are 
capable of bone resorption, but at a less efficient level.  
 
Cathepsin K (Ctsk) 
Bone resorption is a combination of mineral dissolution by acid and collagen 
matrix degradation by proteolytic enzymes. Cathepsin K, primarily expressed in 
osteoclast, is responsible for cleaving type I collagen, the main organic constituent of 
bone. Pycnodysostosis, a human genetic disorder, exhibits a lack of normal collagen 
breakdown resulting in sclerotic bone that is susceptible to fracture due to mutations in 
Ctsk and the phenotype can be reproduced in mice deficient in Ctsk (Goto, Yamaza, & 
Tanaka, 2003). 
 
Tartrate-resistant acid phosphatase (TRAP) 
Tartrate-resistant acid phosphatase (TRAP), also known as acid phosphatase 5 
(Acp5), is widely recognized as a biochemical marker for osteoclast function and a 
terminal differentiation marker for mature osteoclasts. It is ubiquitously expressed in 
many tissues, such as bone, liver, spleen, thymus, and colon. Acp5-/- mice demonstrate 
that the absence of TRAP leads to mild osteopetrosis, associated with reduced 
osteoclastic activity, which impedes endochondral ossification in the development of 
long bones causing shortening and deformation of the limb and axial skeleton. In 
addition, Acp5-/-mice also exhibit reduced immune and inflammatory response due to 
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impaired macrophage function as TRAP is also expressed in macrophages (Hayman & 
Cox, 2003). 
 
Bone morphogenetic proteins and their signaling pathways 
Bone morphogenetic proteins (BMPs) were first discovered by Urist as the 
osteoinductive component of demineralized bone matrix about 40 years ago. Its essential 
role in osteoblast differentiation, survival, and endochondral ossification in 
skeletogenesis, has been firmly established (Biver et al., 2013; X. Li & Cao, 2006). 
BMPs belong to the transforming growth factor- β (TGF- β) superfamily. Among the 
fifteen BMPs found in human, BMP 2, 4, and 6 are secreted by osteoblasts and act as 
autocrine regulators to promote osteogenesis. BMP receptors type I and type II are 
surface serine/threonine kinases that undergo oligomerization and transactivation upon 
activation by BMPs.  
Smad (signal transducing molecules of TGF β superfamily) is the canonical 
signaling pathway of BMPs. After forming heteromeric complex with BMP receptor type 
II, BMP receptor type I initiates Smad signaling via phosphorylation of receptor activated 
Smads (R-Smads-1, -5, and -8), which when phosphorylated, form a heterodimeric 
complex with the common Smad (co-Smad 4). The Smad complex subsequently 
translocates to the nucleus to modulate transcription of BMP target genes (Biver et al., 
2013). 
Non-canonical pathways under BMPs have also been described, in particular the 
MAP kinase (MAPK) signaling axis. It has been suggested that different modes of BMP 
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receptor oligomerization determine the activation of different signaling pathways 
downstream of BMPs (Nohe et al., 2002). Broege et al. demonstrated that the canonical 
(Smad) pathway and non-canonical (MAPK) pathways are activated at different time 
points during osteoclastogenesis. In pre-fusion mononuclear osteoclasts, MAPK pathway 
is utilized to maintain proliferation, survival, and resorption activity (Fong et al., 2013); 
whereas, Smad phosphorylation becomes apparent when fusion is about the take place 
(Broege et al., 2013).  
 
Figure 2. The BMPs and its downstream signaling pathways. BMP signaling can be 
modulated by various extracellular regulators and intracellular inhibitors. BMPs bind to 
surface BMP receptor I and II. Through subsequent activation of the canonical Smad and 
non-canonical Smad-independent pathways, BMPs regulate key genes in osteoblast and 
osteoclast differentiation. 
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Bone Morphogenetic Proteins and Osteoclastogenesis 
Besides its well established role in promoting osteoblast differentiation and bone 
formation, BMPs have been shown to promote osteoclastogenesis as well. However, the 
exact mechanism(s) are still not clear (Giannoudis et al., 2007). BMPs have been 
demonstrated to indirectly, via an osteoblast-dependent manner, stimulate 
osteoclastogenesis and bone resorption. Tachi et al demonstrated that BMP-2, only in the 
presence of 1α,25-dihydroxyvitamin D(3), upregulates the expression of RANKL from 
osteoblasts to promote osteoclastogenesis and fail to do so when co-cultured osteoblasts 
are not activated by vitamin D (Tachi et al., 2010). Kanatani et al showed that BMP-2 
dose dependently stimulated mature osteoclast-like cells only in the presence of stromal 
cells (Kanatani et al., 1995). Abe et al. demonstrated that osteoblastogenesis is a 
prerequisite for osteoclastogenesis by employing a BMP inhibitor, noggin, which did not 
directly act on the osteoclast lineage (Abe et al., 2000). 
On the other hand, convincing data has accumulated to challenge the hypothesis 
that BMPs only affect osteoclast differentiation through an osteoblast-dependent 
mechanism. Kaneko et al. provided strong evidence that BMPs act directly on the 
osteoclast lineage. By isolating osteoclasts from long bones of rabbits, they found BMP 
receptors IA and II on mature osteoclasts. They also demonstrated that BMP-2, without 
exogenous RANKL, directly stimulated bone resorption and upregulated the expression 
of cathepsin K (Kaneko et al., 2000). Itoh et al. presented consistent findings that BMP 
receptor type IA is expressed by both precursors and mature osteoclasts, and BMP-2 
drastically enhanced the differentiation of isolated osteoclasts induced by RANKL and 
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M-CSF (Itoh et al., 2001).  Data from the Mansky/Gopalakrishnan lab has further 
confirmed a direct stimulatory mechanism by BMPs. Enhanced BMP signaling due to the 
loss of Twisted gastrulation, an extracellular BMP inhibitor, leads to increased number, 
size and activity of osteoclasts (Sotillo Rodriguez et al., 2009). Furthermore, Jensen et al. 
demonstrated that exogenous BMP-2 directly enhanced RANKL-dependent formation of 
wild type bone marrow derived osteoclasts and confirmed the endogenous expression of, 
BMP receptors and BMP-2 in osteoclasts (Jensen et al., 2010). More recently, Broege et 
al. demonstrated that loss of expression of BMP receptor type II in osteoclasts result in an 
osteopetrotic mouse phenotype primarily due to a change in the noncanonical MAPK 
signaling by BMP receptors; whereas, the phosphorylation of Smad 1/5 only became 
detectable in osteoclasts around the time of fusion suggesting that the canonical Smad 
signaling pathway may be more involved in regulating fusion of the osteoclast precursors 
(Broege et al., 2013).  
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Goal of the work 
The exact role of Smad signaling in osteoclast differentiation induced by BMP 
remains to be elucidated, and it is the goal of my thesis project to further characterize the 
role of Smad 1/5 and Smad 4 in osteoclastogenesis by using knockdown adenoviral CRE 
recombinase and control osteoclast models. 
 
Hypothesis 
The attenuation of the Smad signaling pathway will negatively impact 
osteoclastogenesis and resorption activity in the presence of RANKL stimulation. 
Specific Aims: 
1. To determine the effects of Smad 1/5, Smad 4 gene deletion by using a CRE 
recombinase adenovirus on histomorphometric measurements of osteoclastic 
differentiation; namely, cell number and cell size (area). 
2. To determine the effects of Smad 1/5, Smad 4 gene deletion by using a CRE 
recombinase adenovirus on osteoclast bone resorption activity. 
3. To determine the effects of Smad 1/5, Smad 4 gene deletion by using a CRE 
recombinase adenovirus on expression of important osteoclastogenesis markers 
using RT-PCR; namely, NFATc1, DC-STAMP and Ctsk. 
4. To determine the necessity of the canonical Smad signaling in BMP enhancement 
of resorption in mature osteoclast by utilizing dorsomorphin, a specific inhibitor 
of Smad 1/5/8 phosphorylation. 
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Materials and Methods 
Transgenic mice 
Smad4fl/fl and Smad1/5fl/fl mice were generated by mating homozygous Smad4fl/fl 
and Smad1/5fl/fl mice.   Smad 1/5 floxed mice obtained from Dr. Stephanie Pangas, 
Baylor College of Medicine, Houston, TX (Pangas et al., 2008) with permission obtained 
from Dr. Elizabeth Robertson (Oxford University, United Kingdom) and Dr. An Zwijsen 
(VIB and Center for Human Genetics, KU Leuven, Belgium) who generated the Smad1 
fl/fl
 and Smad5fl/fl mice, respectively in a mixed background of C57Bl/6 and 129SV.  Smad 
4 floxed mice were obtained from Dr. Michael O’Connor (University of Minnesota).  
Smad 4 floxed mice were originally generated by Dr. Deng (NIH).  Mice were in a 
C57Bl/6 background.  The care and use of the animal in this study followed the standards 
established by the University of Minnesota Institution of Animal Use and Care 
Committee. 
 
Primary Osteoclast Cultures 
Four week old wild type or homozygous floxed mice were sacrificed by CO2 
inhalation for their femurs and tibiae. Bone marrow of the femurs and tibiae was 
collected and cultured in alpha-MEM media for 24 hours in the presence of 50 ng/ml M-
CSF (macrophage-colony stimulating factor) on culture dishes. The non-adherent cells 
were counted and equal numbers were plated (containing primarily of macrophages and 
osteoclast precursors) and cultured for 2 additional days in M-CSF.  The next day cells 
were cultured for an additional 5 days in M-CSF and RANKL (30 ng/ml).  Osteoclast 
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resorption was observed on calcium phosphate plates (Corning). The resorption area was 
observed and captured with light microscopy and the measurements were analyzed using 
NIH Image J. 
 
Adenoviral infection 
Bone marrow macrophages were isolated as described above. Prior stimulation with 
RANKL, the cells were incubated with 100 MOI of adenovirus (EGFP or CRE 
expressing) for 3 hours at 37°C in the presence of M-CSF.  After 3 hours, media 
containing adenovirus was removed and cells were fed with M-CSF and RANKL (30 
ng/ml).  Cells were cultured until multinuclear cells appeared in the control infected 
wells.  RNA was extracted for use in qRT-PCR, protein was extracted for western 
blotting, or cells were stained for TRAP. 
 
TRAP Staining and Histomorphometric Analysis 
Post-infection primary osteoclast cultures were stained for TRAP activity by fixing in 4% 
paraformaldehyde, washing by PBS and staining with acid phosphoric reagents with 
tartrate (5 mg Napthol AS-Mx phosphate, 0.5 l N,N-dimenthyl formamide, 50 ml acetic 
acid buffer (1 ml acetic acid, 6.8 g sodium acetate trihydrate 11.5 g sodium tartarate in 1 
L water), and 25 mg Fast Violet LB salt].  Cells were photographed at 4X and 10X 
magnifications. All TRAP-positive osteoclasts with three or more nuclei were included 
and measured by using NIH Image J software. The average area and number of a given 
10X magnified field was recorded. 
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Quantitative real-time PCR 
To assess the level of differentiation and function of osteoclasts, RT-PCR was employed 
to quantify the expression of the following genetic markers (GAPDH, L4, DCSTAMP 
NFATc1, Smad1, Smad4, Smad5 and cathepsin K). Total RNA was extracted from 
osteoclasts using TRIzol reagent (Invitrogen Life Technologies) and quantitated by UV 
spectroscopy. cDNA was synthesized using the iScript cDNA synthesis kit (Bio-rad) with 
1 ug of extracted RNA. The real time-PCR reaction was performed mixing 1 ul of the 
cDNA and 2X SYBR green (Bio-rad IQ SYBRGreen Supermix) using MyiQ Single-
Color real-time PCR Detection System (Bio-rad) in a MX 3000P QPCR System 
(Stratagene). Amplified genetic markers were normalized to housekeeping genes, 
GAPDH or L4. Primer sequences for the genetic markers are listed as follows:  
GAPDH Forward 5’ TGC ACC ACC AAC TGC TTA 3’  Reverse 5’ GAT GCA GGG 
ATG ATG TTC 3’, L4  Forward 5’ CCT TCT CTG GAA CAA CCT TCT CG 3’  
Reverse 5’ AAG ATG ATG AAC ACC GAC CTT AGC 3’,  DC-STAMP  Forward 5’ 
CAG ACT CCC AAA TGC TGG AT 3’Reverse 5’ CTT GTG GAG GAA CCT AAG 
CG 3’, NFATc1 Forward 5’ TCA TCC TGT CCA ACA CCA AA 3’  Reverse 5’ TCA 
CCC TGG TGT TCT TCC TC 3’, Smad1 Forward 5’ ATG AAT GTG ACC AGC TTG 
TTT 3’  Reverse 5’ CTG CTT GGA ACC AAA TGG GAA 3’, Smad5 Forward 5’ GGA 
ACC TGA GCC ACA ATG AA 3’ Reverse 5’ CTT GCT GGG GAG TTG GGA TA 3’,   
Smad4  Forward 5’ GTG ACG TTT GGG TCA GGT GC 3’ Reverse 5’ TAT GAA CAG 
CGT CGC CAG GT 3’, Cathepsin K Forward 5’ AGG GAA GCA AGC ACT GGA TA 
3’, Reverse 5’ GCT GGC TGG AAT CAC ATC TT 3’. 
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Western Blot 
To determine the level of total Smad 1/5 in osteoclasts, total cell lysate were obtained by 
lysing osteoclasts in modified RIPA buffer in the presence of phosphatase and protease 
(Pierce) inhibitors. Total protein extract was obtained by centrifuging crude cell lysate at 
12,000 rpm at 4 ˚C, resuspended in SDS-PAGE sample buffer, and resolved by SDS-
PAGE.  Resolved proteins were transferred to PVDF membrane (Millipore) and 
immunoblotted against total Smad1/5/8 antibody (Santa Cruz) or total Smad 4 (Cell 
Signaling) and subsequently horseradish peroxidase-conjugated secondary antibodies. 
Immunoreactive protein bands were detected using ECL Plus system (GE Health 
Systems). 
 
Resorption Assays 
Primary osteoclasts were plated on Corning Osteo Assay Surface plates at a 
density of 100,000 cells per well.  Cells were allowed to fully differentiate. For 
resorption assays with BMP2 or dorsomorphin, osteoclasts were allowed to 
differentiate till day 4.  Differentiation medium was supplemented with 50 ng/ml 
BMP2 (R and D Systems) or 1200 nM dorsomorphin (Sigma) overnight.  For all 
the resorption assays, the media was completely removed on day 5 and 100µL/ 
well of 10% bleach was added and allowed to incubate at room temperature for 5 
minutes.  The bleach solution was then aspirated and the wells were washed twice 
with 150µL of dH2O.  The plate was then allowed to air dry completely at room 
temperature for 3-5 hours.  The wells were observed at 10x magnification for the 
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formation of resorption pits and images were captured with light microscopy.  
Images were measured and analyzed using NIH Image J. 
 
Statistical Analysis 
All experiments were repeated three times independently. Real-time PCR were 
performed in duplicates or triplicates and the results were expressed as mean +/- standard 
deviation. All statistical analyses were done by Prism 5 (Graphpad Software). Student’s t-
test was used to test the significance between different test groups. P< 0.05 indicates 
significance. 
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Results 
 
In order to determine the significance of the canonical Smad signaling pathway 
for osteoclastogenesis, transgenic mice that have Smad1/5 flox/flox and Smad4 flox/flox 
genes were generated to allow selective deletion of these genes and their protein 
products. Bone marrow monocytes (BMMs; osteoclast precursors) were isolated from 
transgenic mice as our study model. The rationale for knocking down only Smad 1/5 
instead of all three R-Smads (1/5/8) is that osteoclasts predominantly express Smad 1 and 
5 as shown in Figure 3. BMMs were infected with either a control adenovirus expressing 
EGFP or an adenovirus expression CRE recombinase. It was confirmed by real time RT-
PCR and Western blot that Smad 1/5 (Figure 4) and Smad 4 (Figure 5) expression was 
successfully knocked down in osteoclasts infected with the CRE recombinase adenovirus 
as compared to the control group. 
 
Figure 3. Smad 1 and 5 are the predominant R-Smads expressed in osteoclasts. RNA 
was extracted from wild type BMMs and Smad1/5/8 expression was quantified by RT-
PCR. Error Bar represents standard deviation. 
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Figure 4. Smad 1/5 mRNA and protein expression was successfully knocked down by 
CRE recombinase expressing adenovirus as demonstrated by RT-PCR (top) and Western 
blot (bottom). Ad-control (control expressing EGFP). Ad-CRE (CRE recombinase 
expressing adenovirus). Error bars represent standard deviation. *=p<0.05. ***=p<0.001. 
 
Figure 5. Smad 4 mRNA and protein expression was successfully knocked down by 
CRE expressing adenovirus as demonstrated by RT-PCR (left) and Western blot (right). 
Error bars represent standard deviation. *=p<0.05.  
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Specific Aim 1: 
To determine the impact of Smad 1/5 and Smad 4 gene deletion by using a CRE 
recombinase adenovirus on histomorphometric measurements of osteoclastic 
differentiation; namely, cell number and cell size (area). 
The first aim was to determine the functional impact of Smad 1/5 and Smad 4 
knockdown on osteoclastogenesis. BMMs infected with either control or CRE expressing 
adenoviruses were differentiated in the presence of M-CSF and RANKL for 5 days. 
Osteoclast cultures were fixed and stained for TRAP for histomorphometric 
measurements, namely cell number and cell size. As compared to control group, 
osteoclasts culture deficient in Smad 1/5 expression (Ad-CRE) had less numerous and 
smaller multinucleated osteoclasts (Figure 6). Likewise, when Smad 4 expression was 
knocked down in BMMs, TRAP positive multinucleated osteoclasts were less numerous 
(half as many when compared to control) and smaller (two and half fold smaller when 
compared to control) (Figure 7). 
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Figure 6. Smad1/5 expression is required for osteoclast differentiation. BMMs were 
cultured from Smad1/5 fl/fl mice and infected with either a control (Ad-Control) or CRE 
expression adenovirus (Ad-CRE). They were stimulated by M-CSF and RANKL, TRAP 
stained and imaged (top left and top right). TRAP-positive cells were characterized by 
number (bottom left) and size (bottom right). Values represent the mean with error bar 
representing standard deviation. *=p<0.05, **=p<0.005, ***=p<0.001. 
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Figure 7. Smad4 expression is required for osteoclast differentiation. BMMs were 
cultured from Smad4fl/fl mice and infected with either a control (Ad-Control) or CRE 
expression adenovirus (Ad-CRE). They were stimulated by M-CSF and RANKL, TRAP 
stained and imaged (top left and top right). TRAP-positive cells were characterized by 
number (bottom left) and size (bottom right). Values represent the mean with error bar 
representing standard deviation. ***=p<0.001. 
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Specific Aim 2: 
To determine the effects of Smad 1/5, Smad 4 gene deletion by using a CRE recombinase 
adenovirus on osteoclast bone resorption activity. 
Kaneko et al. demonstrated that BMP2 and BMP4 stimulation increased bone 
resorption activity of rabbit osteoclasts (Kaneko et al., 2000), however, the study did not 
specify if the increase in osteoclastic activity was due to the canonical or non-canonical 
pathway under BMP signaling. Broege et al. and Fong et al. demonstrated that when 
BMPs signal through the non-canonical MAPK pathways, bone resorption is stimulated 
in mature osteoclasts (Broege et al., 2013; Fong et al., 2013). To determine the effects of 
deleting Smad expression on osteoclast activity, Smad 1/5 fl/fl and Smad 4 fl/fl BMMs were 
infected by control and CRE adenovirus and cultured on calcium phosphate coated plates 
in the presence of M-CSF and RANKL for 5 days. Calcium phosphate plates were 
imaged and percent area resorbed was quantified. Smad 1/5 deficiency in osteoclasts led 
to a decrease in the number of resorption pits and lower percent area resorbed (Figure 8). 
Similarly, Smad 4 deficient osteoclasts demonstrated a reduced level of resorption 
activity as demonstrated by resorption pit and percent resorbed area (Figure 9). Smad 4 
Ad-CRE group had a 28-fold decrease in the percent area resorbed. 
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Figure 8. Osteoclast resorption activity is reduced when Smad 1/5 is knocked down. 
BMMs from Smad 1/5fl/fl mice were infected with control (Ad-Control) or CRE 
expressing (Ad-CRE) adenovirus and cultured on calcium phosphate coated plates with 
M-CSF and RANKL. Representative images of calcium phosphate coated plates (left) 
and percent area resorbed quantified (right). Values represent the mean. Error bars 
represent standard deviation. ***=p<0.001. 
 
 
Figure 9. Osteoclast resorption activity is reduced when Smad 4 is knocked down. 
BMMs from Smad 4 fl/fl mice were infected with control (Ad-Control) or CRE expressing 
(Ad-CRE) adenovirus and cultured on calcium phosphate coated plates with M-CSF and 
RANKL. Representative images of calcium phosphate coated plates (left) and percent 
area resorbed quantified (right). Values represent the mean. Error bars represent standard 
deviation. ***=p<0.001 
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Specific Aim 3: 
To determine the effects of Smad 1/5, Smad 4 gene attenuation by using a CRE 
recombinase adenovirus on expression of important osteoclastogenesis markers using 
RT-PCR; namely, Nfatc1, DCSTAMP and Cathepsin K. 
To investigate the possible causes of reduced osteoclast resorption activity, the 
changes in the expression of key osteoclast markers, such as Nfatc1, DCSTAMP, and 
Cathepsin K, was measured in osteoclasts with attenuated of Smad 1/5 and Smad 4 
expression. Osteoclasts were infected with control or CRE expression adenovirus under 
the stimulation of M-CSF and RANKL. RNA was extracted from osteoclast lysate and 
genes of interest were quantified by RT-PCR against a house keeping gene, GAPDH, 
whose expression remains constant under our experimental treatment. In Smad 1/5fl/fl 
osteoclasts, the expression of Nfatc1 was not significantly different between control and 
CRE. However, significant reduction of DCSTAMP and Cathepsin K expression was 
observed when Smad 1/5 expression was attenuated. In the Smad1/5 deficient osteoclasts, 
DCSTAMP and Cathepsin K expression is reduced 2-fold and 2.5-fold, respectively 
(Figure 10). In the Smad 4fl/fl osteoclasts, a significant decrease in the expression of 
Nfatc1, DCSTAMP and Cathepsin K, was observed compared to the control group. 
Nfatc1 had a 12-fold decrease, DCSTAMP had a 3-fold decrease, and Cathepsin K had a 
4-fold decrease compared to the control cells (Figure 11). 
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Figure 10. The expression of osteoclast differentiation markers were reduced in Smad 
1/5 deficient osteoclasts. RNA was extracted from osteoclasts infected by control (Ad-
Control) or CRE (Ad-CRE) expressing adenovirus and Nfatc1, DCSTAMP, and 
Cathepsin K expression levels were measured by RT-PCR. Values represent the mean. 
Error bars represent the standard deviation. ns= not significant. *=p<0.05. ***=p<0.001. 
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Figure 11. The expression of osteoclast differentiation markers were reduced in Smad 4 
deficient osteoclasts. RNA was extracted from osteoclasts infected by control (Ad-
Control) or CRE (Ad-CRE) expressing adenovirus and Nfatc1, DCSTAMP, and 
Cathepsin K expression levels were measured by RT-PCR. Values represent the mean. 
Error bars represent the standard deviation. *=p<0.05. **=p<0.005. 
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Specific Aim 4: 
To determine the necessity of the canonical Smad signaling in BMP enhancement of 
resorption in mature osteoclast by utilizing dorsomorphin, a specific inhibitor of Smad 
1/5/8 phosphorylation. 
The above data demonstrated that osteoclasts in Smad 4 and Smad 1/5 deficient 
mice were smaller and mostly mononucleated and exhibited a reduced ability to resorb 
calcium phosphate plates. This is a consistent finding with the literature where Li et al. 
demonstrated that mononuclear osteoclasts are capable of resorption, but at a lower 
efficiency than multinuclear osteoclasts (Lee et al., 2006). In attempt to explain if the 
reduction of calcium phosphate plate resorption in Smad signaling deficient mice is 
caused by a decrease in osteoclast differentiation or osteoclast activity, normal osteoclasts 
were differentiated for 5 days into fully mature osteoclasts and then treated with RANKL 
or RANKL with exogenous BMP2 for 24 hours. Resorptive activity of mature osteoclasts 
was augmented by BMP2 stimulation as shown by an increase in the total area and total 
number of resorption pits (Figure 12, top).  
To further explore if the canonical Smad signaling pathway mediates the BMP2-
induced enhancement of resorption, mature osteoclasts were treated with RANKL with 
DMSO (control vehicle) or RANKL with dorsomorphin, a known Smad1/5/8 
phosphorylation inhibitor. It was found that dorsomorphin treatment significantly reduced 
the total area, total number and average size of resorption pits (Figure 12, bottom). 
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Figure 12. Activity of mature osteoclasts is regulated by canonical Smad signaling when 
stimulated by BMP2. BMMs from wild type mice were cultured and plated on calcium 
phosphate coated plates in the presence of M-CSF and RANKL until osteoclasts fuse to 
become multinucleated cells. (Top panels) Multinuclear osteoclasts were then stimulated 
in media containing either M-CSF and RANKL or M-CSF and RANKL and BMP2 (50 
ng/ml) for 24 hours. (Bottom Panels) Multinucleated osteoclasts were treated for 24 
hours with either M-CSF + RANKL +DMSO or M-CSF + RANKL + Dorsomorphin 
(1200nM).  Total area resorbed, average size of pits and number of pits were quantitated. 
Total resorption area, average size and number of resorption pits were quantified. Values 
represent the mean. Error bars represent standard deviation. *=p<0.05. **=p<0.001. 
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Discussion 
 
My research project focused on exploring the role of the BMP canonical signaling 
pathway in osteoclastogenesis and resorption activity. Specifically, the expression of 
Smad 4 and Smad 1/5 were selectively attenuated utilizing transgenic mice and 
recombinase expressing adenovirus. We successfully showed that the expression of Smad 
4 and Smad 1/5 are necessary for osteoclast differentiation. Bone marrow monocytes 
from both Smad 4 and Smad 1/5 deficiency mice differentiated less efficiently as shown 
by a decrease in TRAP+ mononuclear osteoclasts that fused poorly as demonstrated by 
smaller multinuclear osteoclasts, when compared to control group. When osteoclasts are 
stimulated by BMP, Smad 1/5 and Smad 4 form a transcription complex that relocates to 
the nucleus to regulate gene expression involved in osteoclastogenesis and activation. 
When Smad 4 and Smad1/5 expression was attenuated, changes in the expression of key 
osteoclast differentiation markers were observed. DCSTAMP and Cathepsin K expression 
were decreased in both Smad 1/5 and Smad 4 deficient osteoclasts; whereas, Nfatc1 
expression was only reduced in Smad 4 knockdown osteoclasts, but not in Smad 1/5 
knockdown osteoclasts. Furthermore, consistent with the morphologic and genetic 
changes, Smad 4 and Smad 1/5 deficient osteoclasts demonstrated less resorption activity 
on calcium phosphate plates. Finally, BMP2 and dorsomorphin, through their respective 
positive and negative effects on Smad proteins, are capable of modulating the resorption 
activity of mature osteoclasts. These data strongly support our hypothesis that “The 
attenuation of the Smad signaling pathway will negatively impact osteoclastogenesis and 
resorption activity in the presence of RANKL stimulation”. 
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Previous data from Rodriguez et al. demonstrated that increasing BMP signaling 
by attenuation of the expression of a BMP inhibitor, Twisted gastrulation, leads to an 
increase in number and size of wild type osteoclasts (Sotillo Rodriguez et al., 2009). It 
was noted that Smad 1/5/8 were phosphorylated to a higher level in those large 
multinucleated osteoclasts when compared to wild type mice. The increase in 
phosphorylation of Smad 1/5/8 appears to coincide with the time when mononuclear 
osteoclasts begin to fuse. In addition, noggin, a BMP antagonist, only successfully 
inhibited osteoclast differentiation prior to the time of fusion (Jensen et al., 2010). In 
combination of our finding that a reduction in the expression of Smad 1/5 leads to smaller 
and fewer of multinucleated osteoclasts, it appears that Smad 1/5 is necessary for the 
fusion of mononuclear osteoclasts. Broege et al. successfully demonstrated that the 
MAPK non-canonical pathway under BMP signaling is necessary for osteoclast 
differentiation (Broege et al., 2013). Our data in this study further confirms the 
importance of BMP signaling in osteoclastogenesis that the Smad canonical pathway also 
is necessary for osteoclast differentiation. 
Smad 4 and Smad 1/5 null osteoclasts exhibited similar phenotypes for most of 
the parameters measured in this project. However, their influence on the expression of the 
Nfatc1 was different in that only Smad 4 deficient osteoclasts showed a reduction in 
Nfatc1 expression. Smad 4 is named the common-Smad because it is shared by both 
BMP and TGF-β signaling. Abundant evidence from the literature supports the regulatory 
role of TGF-β in osteoblasts and osteoclasts. TGF-β has been demonstrated to be required 
for monocyte to commit to the osteoclast lineage (Karsdal et al., 2003) and it also 
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enhances osteoclast formation induced by RANKL (Fuller, Lean, Bayley, Wani, & 
Chambers, 2000). The dual role of Smad 4 in BMP and TGF-β may provide an 
explanation for the additional reduction of Nfatc1 expression observed in Smad 4 
deficient osteoclasts when compared to Smad 1/5 deficient osteoclasts. It can be 
speculated that TGF-β signaling through Smad 4 exerts more regulation on Nfatc1 
expression whereas BMP signaling through Smad 1/5 regulates genes involved in fusion, 
such as DC-STAMP. In fact, osteoclasts treated with dorsomorphin (inhibitor of 
Smad1/5/8 phosphorylation) showed a reduction in DC-STAMP expression (Broege et al., 
2013). Osteoclasts had an increase in Nfatc1 expression when treated with M-CSF, 
RANKL and TGF-β instead of M-CSF and RANKL alone (Fox, Evans, & Lovibond, 
2008). Therefore, a change in TGF-β signaling in Smad 4 deficient osteoclasts may have 
led to the reduction of Nfatc1 expression observed in our data; whereas, Smad 1/5 
deficient osteoclasts have no effect on the expression of Nfatc1. 
BMP9 has been shown to enhance the ability of mature osteoclast to resorb bone. 
It was demonstrated that this effect of BMP9 is mediated through the non-canonical BMP 
signaling, in particular the ERK signaling pathway was activated by BMP9 (Fong et al., 
2013). In our study, we demonstrated that BMP2 also augments calcium phosphate 
resorption when added to mature osteoclast cultures and BMP2’s effect is mediated 
through the canonical Smad signaling. This finding provides evidence that Smad 
signaling not only has a role in regulating mononuclear osteoclast fusion, but also 
controls osteoclast resorption activity. 
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Conclusion 
Diseases involving uncontrolled bone resorption cause significant socio-economic 
burden and suffering. It is, therefore, a pressing matter to understand how osteoclast 
differentiation and activity are regulated to devise appropriate therapy to tackle the 
diseases. In addition, there has been a steady paradigm shift in the interest of orthodontic 
research from appliance mechanics to biology-based therapies, such as accelerated 
osteogenic orthodontics (commonly known as Wilckodontics) and Acceledent®. Locally 
delivered gene-therapy (local RANKL gene transfer) and pharmalogical approaches 
(local injection of bisphosphonates) have specifically targeted regional osteoclast 
differentiation and activity in the alveolar bone in attempt to modulate orthodontic tooth 
movement (Kanzaki et al., 2006; Rinchuse, Sosovicka, Robison, & Pendleton, 2007). It is 
obvious that more knowledge of how osteoclast differentiation and activity are regulated 
is necessary for the advancement of biology-based orthodontic therapies. BMP signaling 
provides a new avenue for the regulation of osteoclast differentiation and may be a 
potential therapeutic target. From this study, we have demonstrated that Smad 1/5 and 
Smad 4 of the canonical BMP signaling are essential for osteoclast differentiation and 
activity and they are the mediators for the enhancement of osteoclast resorption when 
stimulated by BMP2. 
 
  34 
References 
 
Abe, E., Yamamoto, M., Taguchi, Y., Lecka-Czernik, B., O'Brien, C. A., Economides, A. 
N., . . . Manolagas, S. C. (2000). Essential requirement of BMPs-2/4 for both 
osteoblast and osteoclast formation in murine bone marrow cultures from adult 
mice: antagonism by noggin. J Bone Miner Res, 15(4), 663-673. doi: 
10.1359/jbmr.2000.15.4.663 
Biver, E., Hardouin, P., & Caverzasio, J. (2013). The "bone morphogenic proteins" 
pathways in bone and joint diseases: translational perspectives from 
physiopathology to therapeutic targets. Cytokine Growth Factor Rev, 24(1), 69-
81. doi: 10.1016/j.cytogfr.2012.06.003 
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003). Osteoclast differentiation and 
activation. Nature, 423(6937), 337-342. doi: 10.1038/nature01658 
Broege, A., Pham, L., Jensen, E. D., Emery, A., Huang, T. H., Stemig, M., . . . 
Gopalakrishnan, R. (2013). Bone morphogenetic proteins signal via SMAD and 
mitogen-activated protein (MAP) kinase pathways at distinct times during 
osteoclastogenesis. J Biol Chem, 288(52), 37230-37240. doi: 
10.1074/jbc.M113.496950 
Fong, D., Bisson, M., Laberge, G., McManus, S., Grenier, G., Faucheux, N., & Roux, S. 
(2013). Bone morphogenetic protein-9 activates Smad and ERK pathways and 
supports human osteoclast function and survival in vitro. Cell Signal, 25(4), 717-
728. doi: 10.1016/j.cellsig.2012.12.003 
Fox, S. W., Evans, K. E., & Lovibond, A. C. (2008). Transforming growth factor-beta 
enables NFATc1 expression during osteoclastogenesis. Biochem Biophys Res 
Commun, 366(1), 123-128. doi: 10.1016/j.bbrc.2007.11.120 
Fuller, K., Lean, J. M., Bayley, K. E., Wani, M. R., & Chambers, T. J. (2000). A role for 
TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci, 113 ( Pt 13), 
2445-2453.  
Giannoudis, P. V., Kanakaris, N. K., & Einhorn, T. A. (2007). Interaction of bone 
morphogenetic proteins with cells of the osteoclast lineage: review of the existing 
evidence. Osteoporos Int, 18(12), 1565-1581. doi: 10.1007/s00198-007-0441-x 
Goto, T., Yamaza, T., & Tanaka, T. (2003). Cathepsins in the osteoclast. J Electron 
Microsc (Tokyo), 52(6), 551-558.  
Hayman, A. R., & Cox, T. M. (2003). Tartrate-resistant acid phosphatase knockout mice. 
J Bone Miner Res, 18(10), 1905-1907. doi: 10.1359/jbmr.2003.18.10.1905 
Henriksen, K., Neutzsky-Wulff, A. V., Bonewald, L. F., & Karsdal, M. A. (2009). Local 
communication on and within bone controls bone remodeling. Bone, 44(6), 1026-
1033. doi: 10.1016/j.bone.2009.03.671 
Itoh, K., Udagawa, N., Katagiri, T., Iemura, S., Ueno, N., Yasuda, H., . . . Takahashi, N. 
(2001). Bone morphogenetic protein 2 stimulates osteoclast differentiation and 
survival supported by receptor activator of nuclear factor-kappaB ligand. 
Endocrinology, 142(8), 3656-3662. doi: 10.1210/endo.142.8.8300 
Jensen, E. D., Pham, L., Billington, C. J., Espe, K., Carlson, A. E., Westendorf, J. J., . . . 
Mansky, K. (2010). Bone morphogenic protein 2 directly enhances differentiation 
  35 
of murine osteoclast precursors. J Cell Biochem, 109(4), 672-682. doi: 
10.1002/jcb.22462 
Kanatani, M., Sugimoto, T., Kaji, H., Kobayashi, T., Nishiyama, K., Fukase, M., . . . 
Chihara, K. (1995). Stimulatory effect of bone morphogenetic protein-2 on 
osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res, 
10(11), 1681-1690. doi: 10.1002/jbmr.5650101110 
Kaneko, H., Arakawa, T., Mano, H., Kaneda, T., Ogasawara, A., Nakagawa, M., . . . 
Hakeda, Y. (2000). Direct stimulation of osteoclastic bone resorption by bone 
morphogenetic protein (BMP)-2 and expression of BMP receptors in mature 
osteoclasts. Bone, 27(4), 479-486.  
Kanzaki, H., Chiba, M., Arai, K., Takahashi, I., Haruyama, N., Nishimura, M., & Mitani, 
H. (2006). Local RANKL gene transfer to the periodontal tissue accelerates 
orthodontic tooth movement. Gene Ther, 13(8), 678-685. doi: 
10.1038/sj.gt.3302707 
Karsdal, M. A., Hjorth, P., Henriksen, K., Kirkegaard, T., Nielsen, K. L., Lou, H., . . . 
Foged, N. T. (2003). Transforming growth factor-beta controls human 
osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J 
Biol Chem, 278(45), 44975-44987. doi: 10.1074/jbc.M303905200 
Kim, K., Lee, S. H., Ha Kim, J., Choi, Y., & Kim, N. (2008). NFATc1 induces osteoclast 
fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific 
transmembrane protein (DC-STAMP). Mol Endocrinol, 22(1), 176-185. doi: 
10.1210/me.2007-0237 
Kong, Y. Y., Yoshida, H., Sarosi, I., Tan, H. L., Timms, E., Capparelli, C., . . . 
Penninger, J. M. (1999). OPGL is a key regulator of osteoclastogenesis, 
lymphocyte development and lymph-node organogenesis. Nature, 397(6717), 
315-323. doi: 10.1038/16852 
Lee, S. H., Rho, J., Jeong, D., Sul, J. Y., Kim, T., Kim, N., . . . Choi, Y. (2006). v-
ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and 
increased bone formation. Nat Med, 12(12), 1403-1409. doi: 10.1038/nm1514 
Li, J., Sarosi, I., Yan, X. Q., Morony, S., Capparelli, C., Tan, H. L., . . . Boyle, W. J. 
(2000). RANK is the intrinsic hematopoietic cell surface receptor that controls 
osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc 
Natl Acad Sci U S A, 97(4), 1566-1571.  
Li, X., & Cao, X. (2006). BMP signaling and skeletogenesis. Ann N Y Acad Sci, 1068, 
26-40. doi: 10.1196/annals.1346.006 
Mellis, D. J., Itzstein, C., Helfrich, M. H., & Crockett, J. C. (2011). The skeleton: a multi-
functional complex organ: the role of key signalling pathways in osteoclast 
differentiation and in bone resorption. J Endocrinol, 211(2), 131-143. doi: 
10.1530/JOE-11-0212 
Menaa, C., Kurihara, N., & Roodman, G. D. (2000). CFU-GM-derived cells form 
osteoclasts at a very high efficiency. Biochem Biophys Res Commun, 267(3), 943-
946. doi: 10.1006/bbrc.1999.2042 
Miyamoto, T. (2011). Regulators of osteoclast differentiation and cell-cell fusion. Keio J 
Med, 60(4), 101-105.  
  36 
Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-Hora, M., Feng, J. Q., . . . 
Takayanagi, H. (2011). Evidence for osteocyte regulation of bone homeostasis 
through RANKL expression. Nat Med, 17(10), 1231-1234. doi: 10.1038/nm.2452 
Nohe, A., Hassel, S., Ehrlich, M., Neubauer, F., Sebald, W., Henis, Y. I., & Knaus, P. 
(2002). The mode of bone morphogenetic protein (BMP) receptor oligomerization 
determines different BMP-2 signaling pathways. J Biol Chem, 277(7), 5330-5338. 
doi: 10.1074/jbc.M102750200 
Pangas, S. A., Li, X., Umans, L., Zwijsen, A., Huylebroeck, D., Gutierrez, C., . . . 
Matzuk, M. M. (2008). Conditional deletion of Smad1 and Smad5 in somatic cells 
of male and female gonads leads to metastatic tumor development in mice. Mol 
Cell Biol, 28(1), 248-257. doi: 10.1128/MCB.01404-07 
Rinchuse, D. J., Sosovicka, M. F., Robison, J. M., & Pendleton, R. (2007). Orthodontic 
treatment of patients using bisphosphonates: a report of 2 cases. Am J Orthod 
Dentofacial Orthop, 131(3), 321-326. doi: 10.1016/j.ajodo.2006.11.002 
Sotillo Rodriguez, J. E., Mansky, K. C., Jensen, E. D., Carlson, A. E., Schwarz, T., Pham, 
L., . . . Gopalakrishnan, R. (2009). Enhanced osteoclastogenesis causes osteopenia 
in twisted gastrulation-deficient mice through increased BMP signaling. J Bone 
Miner Res, 24(11), 1917-1926. doi: 10.1359/jbmr.090507 
Tachi, K., Takami, M., Zhao, B., Mochizuki, A., Yamada, A., Miyamoto, Y., . . . Kamijo, 
R. (2010). Bone morphogenetic protein 2 enhances mouse osteoclast 
differentiation via increased levels of receptor activator of NF-κB ligand 
expression in osteoblasts. Cell Tissue Res, 342(2), 213-220. doi: 10.1007/s00441-
010-1052-y 
Takayanagi, H. (2007). The role of NFAT in osteoclast formation. Ann N Y Acad Sci, 
1116, 227-237. doi: 10.1196/annals.1402.071 
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., . . . Taniguchi, 
T. (2002). Induction and activation of the transcription factor NFATc1 (NFAT2) 
integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell, 
3(6), 889-901.  
Udagawa, N., Takahashi, N., Yasuda, H., Mizuno, A., Itoh, K., Ueno, Y., . . . Suda, T. 
(2000). Osteoprotegerin produced by osteoblasts is an important regulator in 
osteoclast development and function. Endocrinology, 141(9), 3478-3484. doi: 
10.1210/endo.141.9.7634 
Väänänen, H. K., & Laitala-Leinonen, T. (2008). Osteoclast lineage and function. Arch 
Biochem Biophys, 473(2), 132-138. doi: 10.1016/j.abb.2008.03.037 
Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., . . . Suda, 
T. (2005). DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign 
body giant cells. J Exp Med, 202(3), 345-351. doi: 10.1084/jem.20050645 
Yavropoulou, M. P., & Yovos, J. G. (2008). Osteoclastogenesis--current knowledge and 
future perspectives. J Musculoskelet Neuronal Interact, 8(3), 204-216.  
Zaidi, M. (2007). Skeletal remodeling in health and disease. Nature Medicine, 13(7), 791-
801. doi: 10.1038/nm1593 
 
 
